Contraction inhibits insulin-stimulated insulin receptor substrate-1/2-associated phosphoinositide 3-kinase activity, but not protein kinase B activation or glucose uptake, in rat muscle
Jp. Whitehead et al., Contraction inhibits insulin-stimulated insulin receptor substrate-1/2-associated phosphoinositide 3-kinase activity, but not protein kinase B activation or glucose uptake, in rat muscle, BIOCHEM J, 349, 2000, pp. 775-781
The initial stages of insulin-stimulated glucose uptake are thought to invo
lve tyrosine phosphorylation of insulin receptor substrates (IRSs), which r
ecruit and activate phosphoinositide 3-kinase (PI 3-kinase), leading to the
activation of protein kinase B (PKB) and other downstream effecters. In co
ntrast, contraction stimulates glucose uptake via a PI 3-kinase-independent
mechanism. The combined effects of insulin and contraction on glucose upta
ke are additive. However, it has been reported that contraction causes a de
crease in insulin-stimulated IRS-1-associated PI 3-kinase activity. To inve
stigate this paradox, we have examined the effects of contraction on insuli
n-stimulated glucose uptake and proximal insulin-signalling events in isola
ted rat epitrochlearis muscle. Stimulation by insulin or contraction produc
ed a 3-fold increase in glucose uptake, with the effects of simultaneous tr
eatment by insulin and contraction being additive. Wortmannin completely bl
ocked the additive effect of insulin in contracting skeletal muscle, indica
ting that this is a PI 3-kinase-dependent effect. Insulin-stimulated recrui
tment of PI 3-kinase to IRS-1 was unaffected by contraction; however, insul
in produced no discernible increase in PI 3-kinase activity in IRS-1 or IRS
-2 immunocomplexes in contracting skeletal muscle. Consistent with this, co
ntraction inhibited insulin-stimulated p70(S6K) activation. In contrast, in
sulin-stimulated activation of PKB was unaffected by contraction. Thus, in
contracting skeletal muscle, insulin stimulates glucose uptake and activate
s PKB, but not p70(S6K), by a PI 3-kinase-dependent mechanism that is indep
endent of changes in IRS-1- and IRS-2-associated PI 3-kinase activity.